New AtlasFunctional synthetic enzyme could be catalyst for artificial lifeNew AtlasWhile the researchers are still playing with the building blocks of life, a functional artificial enzyme is an important step towards developing truly synthetic biology… Continue reading
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in …GlobeNewswire (press release)COPENHAGEN, Denmark, January 19, 2018 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initia… Continue reading
Food Safety NewsBriefly: Pufferfish poison — Sail or fail — CRISPR mushroomsFood Safety NewsAn acronym for clustered regularly interspaced short palindromic repeats, CRISPR technology is a method for modifying the genome of an organism by “precisely de… Continue reading
MIT NewsProgrammable dropletsMIT NewsThe new approach, which moves solutions around in computationally prescribed patterns, could enable experiments to be conducted more efficiently, cost-effectively, and at larger scales. “Traditional microfluidic sys… Continue reading
European Patent Office revokes Broad Institute CRISPR patentBioWorld OnlineDUBLIN – The epic CRISPR/Cas9 patent wars took another intriguing twist this week, when the European Patent Office (EPO) revoked a Broad Institute European patent, EP 2771468 … Continue reading
OncLiveDr. Maloney on Targets for CAR T-Cell TherapyOncLiveDavid Maloney, MD, PhD, professor of medicine, Division of Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the success and chal… Continue reading
|
Researchers create first stem cells using CRISPR genome activation
Phys.Org The latest study, published in Cell Stem Cell, offers a third way to turn skin cells into stem cells by directly manipulating the cells’ genome using CRISPR gene regulation techniques. “Having different options to make iPSCs will be useful when … |
Science Magazine |
Broad Institute takes a hit in European CRISPR patent struggle
Science Magazine A decision from the European Patent Office (EPO) has put the Broad Institute in Cambridge, Massachusetts, on shaky ground with its intellectual property claims to the gene-editing tool CRISPR. EPO yesterday revoked a patent granted to the Broad for … UPDATE: Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European PatentGenomeWeb CRISPR: the gene editing tool making the world go roundLexology Mixed views on Broad’s fate after EPO revokes CRISPR patentLife Sciences Intellectual Property Review The Pharma Letter all 4 news articles » |